What Medlive Technology Co., Ltd.'s (HKG:2192) 25% Share Price Gain Is Not Telling You
May 07
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Healthtech Industry Analysis
UpdatedMay 15, 2025
DataAggregated Company Financials
Companies7
- 7D5.3%
- 3M11.6%
- 1Y14.2%
- YTDn/a
Over the last 7 days, the Healthtech industry has dropped 1.4%, driven by a pullback from Medlive Technology of 3.0%. This takes the industry's 12 month performance to a gain of 14%. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the Hong Kong Healthtech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 15 May 2025 | HK$34.1b | HK$3.7b | -HK$198,209,287.85 | 24.6x | -171.9x | 9.3x |
| Sat, 12 Apr 2025 | HK$26.5b | HK$3.6b | -HK$194,421,669.72 | 19x | -136.3x | 7.3x |
| Mon, 10 Mar 2025 | HK$40.4b | HK$3.5b | -HK$221,061,877.84 | 13.7x | -183x | 11.5x |
| Wed, 05 Feb 2025 | HK$25.6b | HK$3.5b | -HK$221,088,497.71 | 10.3x | -115.7x | 7.2x |
| Fri, 03 Jan 2025 | HK$27.4b | HK$3.5b | -HK$219,257,446.58 | 21.6x | -125.1x | 7.8x |
| Sun, 01 Dec 2024 | HK$17.3b | HK$2.9b | -HK$30,950,561.22 | 17.7x | -557.6x | 6x |
| Tue, 29 Oct 2024 | HK$17.7b | HK$3.6b | -HK$458,123,386.70 | 17.2x | -38.7x | 4.9x |
| Thu, 26 Sep 2024 | HK$13.2b | HK$3.0b | -HK$67,760,263.22 | 18.2x | -194.5x | 4.4x |
| Sat, 24 Aug 2024 | HK$13.3b | HK$3.0b | -HK$90,447,626.53 | 17.7x | -147.2x | 4.5x |
| Mon, 22 Jul 2024 | HK$14.5b | HK$2.9b | -HK$88,905,228.89 | 18.9x | -162.7x | 5x |
| Wed, 19 Jun 2024 | HK$15.2b | HK$2.8b | -HK$256,141,799.91 | 21.1x | -59.2x | 5.5x |
| Fri, 17 May 2024 | HK$16.7b | HK$2.8b | -HK$257,435,041.45 | 23.2x | -64.7x | 6x |
| Sun, 14 Apr 2024 | HK$15.7b | HK$2.8b | -HK$257,734,195.19 | 22.1x | -60.8x | 5.6x |
| Tue, 12 Mar 2024 | HK$15.1b | HK$2.1b | -HK$173,547,371.68 | 26.2x | -87x | 7.1x |
| Thu, 08 Feb 2024 | HK$13.4b | HK$2.1b | -HK$175,340,712.59 | 23x | -76.5x | 6.3x |
| Sat, 06 Jan 2024 | HK$15.9b | HK$2.1b | -HK$174,740,011.00 | 26.5x | -90.8x | 7.4x |
| Mon, 04 Dec 2023 | HK$18.2b | HK$2.1b | -HK$174,582,567.00 | 33.4x | -104.1x | 8.5x |
| Wed, 01 Nov 2023 | HK$15.6b | HK$2.2b | -HK$467,611,581.00 | 28x | -33.4x | 7.1x |
| Fri, 29 Sep 2023 | HK$16.6b | HK$2.2b | -HK$468,560,110.00 | 28.8x | -35.4x | 7.5x |
| Sun, 27 Aug 2023 | HK$12.2b | HK$1.7b | -HK$635,950,172.00 | 29.1x | -19.2x | 7x |
| Tue, 25 Jul 2023 | HK$13.4b | HK$1.7b | -HK$689,813,031.00 | 36.2x | -19.5x | 7.8x |
| Thu, 22 Jun 2023 | HK$14.0b | HK$2.2b | -HK$742,727,963.00 | 35.7x | -18.9x | 6.5x |
| Sat, 20 May 2023 | HK$13.8b | HK$2.2b | -HK$760,789,417.00 | 36.2x | -18.1x | 6.2x |
| Mon, 17 Apr 2023 | HK$19.2b | HK$2.3b | -HK$779,910,219.00 | 44x | -24.6x | 8.4x |
| Wed, 15 Mar 2023 | HK$18.4b | HK$2.2b | -HK$874,396,902.00 | 84.3x | -21.1x | 8.3x |
| Fri, 10 Feb 2023 | HK$22.9b | HK$2.6b | -HK$978,304,747.00 | 91.3x | -23.4x | 8.9x |
| Sun, 08 Jan 2023 | HK$19.4b | HK$2.5b | -HK$965,076,442.00 | 75.7x | -20.1x | 7.7x |
| Tue, 06 Dec 2022 | HK$20.4b | HK$2.5b | -HK$939,751,046.00 | 88.2x | -21.8x | 8.3x |
| Thu, 03 Nov 2022 | HK$15.3b | HK$2.4b | -HK$1,011,953,692.00 | 65.9x | -15.1x | 6.3x |
| Sat, 01 Oct 2022 | HK$16.5b | HK$2.5b | -HK$1,024,291,693.00 | 71.9x | -16.1x | 6.7x |
| Mon, 29 Aug 2022 | HK$23.1b | HK$2.5b | -HK$1,042,920,289.00 | 94.4x | -22.1x | 9.1x |
| Wed, 27 Jul 2022 | HK$20.4b | HK$2.2b | -HK$1,088,524,678.00 | 162.2x | -18.8x | 9.2x |
| Fri, 24 Jun 2022 | HK$19.6b | HK$2.0b | -HK$3,657,172,478.00 | 142.8x | -5.4x | 9.7x |
| Sun, 22 May 2022 | HK$18.6b | HK$2.0b | -HK$3,660,751,610.00 | 134.1x | -5.1x | 9.2x |
Price to Earnings Ratio
-5.1x
Current Industry PE
- Investors are optimistic on the Hong Kong Health Care Technology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 7.2x is lower than the industry's current PS ratio of 8.7x.
Past Earnings Growth
- The earnings for companies in the Health Care Technology industry have improved over the last three years.
- Revenues for these companies have grown 22% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Hong Kong Healthtech compare with similar industries?
| HK Market | 3.79% | |
| Healthcare | 0.16% | |
| Healthtech | 5.26% | |
| Healthtech | 5.26% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2506 Xunfei Healthcare Technology | HK$120.20 | 11.1% +HK$1.5b | n/a | PS18.3x | |
| 6681 BrainAurora Medical Technology | HK$6.47 | 6.6% +HK$506.5m | n/a | PS61.8x | |
| 2192 Medlive Technology | HK$12.00 | 1.2% +HK$102.6m | 43.4% | PE25.8x | |
| 2251 Beijing Airdoc Technology | HK$13.04 | 7.4% +HK$91.9m | -17.6% | PS7.9x | |
| 2415 MedSci Healthcare Holdings | HK$1.24 | 10.7% +HK$64.9m | -56.3% | PE24.8x |
